Albertsons Q2 adj. EPS $0.44 vs $0.51 YoY; announces $750M ASR, raises FY25 EPS outlook

Albertsons Companies, Inc.

2025-Q2 EPS reported $0.71 revenue$43,796,600,000

Net income $168.5M ($0.30/sh) vs $145.5M ($0.25) YoY; adjusted net income $248.4M ($0.44/sh) down from $301M ($0.51).
Identical sales up 2.2% (adj); digital sales +23%; loyalty members +13% to 48.7M.
Gross margin rate decreased to 27.0% from 27.6%, pressured by pharmacy growth and digital costs.
Entered $750M accelerated share repurchase with JPMorgan; Board increased repurchase program to $2.75B.
FY2025 outlook raised: identical sales 2.2%-2.75%, adj. EPS $2.06-$2.19, capex $1.8B-$1.9B.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001646972-25-000080
form_type: 8-K
ticker: ACI
cik: 0001646972
company_name: Albertsons Companies, Inc.
filed_at: 2025-10-14T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.037251+00:00
generated_at: 2026-05-17T03:54:32.994229+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001646972-25-000080
json_url: https://secwatch.observer/filing/0001646972-25-000080.json
markdown_url: https://secwatch.observer/filing/0001646972-25-000080.md
text_url: https://secwatch.observer/filing/0001646972-25-000080.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1646972/000164697225000080/0001646972-25-000080-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1646972/000164697225000080/aci-20251014.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001646972-25-000080

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.